UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Regulation of hematopoietic and leukemic stem cells by the immune system

Cell death and differentiation, 2015-02, Vol.22 (2), p.187-198

2015

Volltextzugriff (PDF)

LIGHT/LTβR signaling regulates self-renewal and differentiation of hematopoietic and leukemia stem cells

Nature communications, 2021-02, Vol.12 (1), p.1065-16, Article 1065

2021

Volltextzugriff (PDF)

Control of Early Viral and Bacterial Distribution and Disease by Natural Antibodies

Science (American Association for the Advancement of Science), 1999-12, Vol.286 (5447), p.2156-2159

1999

Volltextzugriff (PDF)

Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, phase II ARTE trial

Annals of oncology, 2018-06, Vol.29 (6), p.1423-1430

2018

Volltextzugriff (PDF)

Chemotherapy negatively impacts the tumor immune microenvironment in NSCLC: an analysis of pre- and post-treatment biopsies in the multi-center SAKK19/09 study

Cancer Immunology, Immunotherapy, 2021-02, Vol.70 (2), p.405-415

2021

Volltextzugriff (PDF)

Blocking programmed cell death 1 in combination with adoptive cytotoxic T-cell transfer eradicates chronic myelogenous leukemia stem cells

Leukemia, 2015-08, Vol.29 (8), p.1781-1785

2015

Volltextzugriff (PDF)

Circulating microRNA profiling in patients with advanced non-squamous NSCLC receiving bevacizumab/erlotinib followed by platinum-based chemotherapy at progression (SAKK 19/05)

Lung cancer (Amsterdam, Netherlands), 2014-08, Vol.85 (2), p.306-313

2014

Volltextzugriff (PDF)

First-line temozolomide combined with bevacizumab in metastatic melanoma: a multicentre phase II trial (SAKK 50/07)

Annals of oncology, 2012-02, Vol.23 (2), p.531-536

2012

Volltextzugriff (PDF)

Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trials

ESMO open, 2022-04, Vol.7 (2), p.100455-100455, Article 100455

2022

Volltextzugriff (PDF)

Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction

Nature (London), 2001-06, Vol.411 (6841), p.1058-1064

2001

Volltextzugriff (PDF)

Immune Surveillance Against a Solid Tumor Fails because of Immunological Ignorance

Proceedings of the National Academy of Sciences - PNAS, 1999-03, Vol.96 (5), p.2233-2238

1999

Volltextzugriff (PDF)

FTY720 Immunosuppression Impairs Effector T Cell Peripheral Homing Without Affecting Induction, Expansion, and Memory

The Journal of immunology (1950), 2000-06, Vol.164 (11), p.5761-5770

2000

Volltextzugriff (PDF)

P16.19 THE EFFECTS OF BEVACIZUMAB ON MR-IMAGING AND 1H-MR-SPECTROSCOPY (MRS) IN PATIENTS WITH HIGH GRADE GLIOMAS

Neuro-oncology (Charlottesville, Va.), 2014-09, Vol.16 (suppl 2), p.ii82-ii82

2014

Volltextzugriff (PDF)

Corrigendum to 'Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trials': [ESMO Open Volume 7, Issue 2, (2022), 100455]

ESMO open, 2022-06, Vol.7 (3), p.100494-100494, Article 100494

2022

Volltextzugriff (PDF)

IgD can largely substitute for loss of IgM function in B cells

Nature (London), 1998-06, Vol.393 (6687), p.797-801

1998

Volltextzugriff (PDF)

143PD Bevacizumab and pemetrexed versus pemetrexed alone as maintenance therapy for patients with advanced nonsquamous NSCLC: Results of the expanded SAKK19/09 trial

Journal of thoracic oncology, 2016-04, Vol.11 (4), p.S120-S120

2016

Volltextzugriff (PDF)

Immunotherapy with dendritic cells directed against tumor antigens shared with normal host cells results in severe autoimmune disease

The Journal of experimental medicine, 2000-03, Vol.191 (5), p.795-804

2000

Volltextzugriff (PDF)

Principles of tumor immunosurveillance and implications for immunotherapy

Cancer gene therapy, 2002-12, Vol.9 (12), p.1043-1055

Ochsenbein, Adrian F

2002

Volltextzugriff (PDF)

Protective Long-Term Antibody Memory by Antigen-Driven and T Help-Dependent Differentiation of Long-Lived Memory B Cells to Short-Lived Plasma Cells Independent of Secondary Lymphoid Organs

Proceedings of the National Academy of Sciences - PNAS, 2000-11, Vol.97 (24), p.13263-13268

2000

Volltextzugriff (PDF)

Rapid Peptide Turnover and Inefficient Presentation of Exogenous Antigen Critically Limit the Activation of Self-Reactive CTL by Dendritic Cells

The Journal of immunology (1950), 2001-03, Vol.166 (6), p.3678-3687

2001

Volltextzugriff (PDF)

Immunological ignorance of solid tumors

Seminars in immunopathology, 2005-06, Vol.27 (1), p.19-35

Ochsenbein, Adrian F

2005

Volltextzugriff (PDF)

Quantification of fetomaternal hemorrhage by fluorescence microscopy is equivalent to flow cytometry

Transfusion (Philadelphia, Pa.), 2002-07, Vol.42 (7), p.947-953

2002

Volltextzugriff (PDF)

CD127+ innate lymphoid cells are dysregulated in treatment naïve acute myeloid leukemia patients at diagnosis

Haematologica (Roma), 2015-07, Vol.100 (7), p.e257-e260

2015

Volltextzugriff (PDF)

P06.08.B Radiation therapy enhances anti-tumor activity of a MET CAR T-based immunotherapy for glioblastoma

Neuro-oncology (Charlottesville, Va.), 2022-09, Vol.24 (Supplement_2), p.ii39-ii39

2022

Volltextzugriff (PDF)

A Comparison of T Cell Memory against the Same Antigen Induced by Virus versus Intracellular Bacteria

Proceedings of the National Academy of Sciences - PNAS, 1999-08, Vol.96 (16), p.9293-9298

1999

Volltextzugriff (PDF)

1 – 25 von 848

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(748)
Mit Volltextzugriff
(708)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Regulation of hematopoietic and leukemic stem cells by the immune system

LIGHT/LTβR signaling regulates self-renewal and differentiation of hematopoietic and leukemia stem cells

Control of Early Viral and Bacterial Distribution and Disease by Natural Antibodies

Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, phase II ARTE trial

Chemotherapy negatively impacts the tumor immune microenvironment in NSCLC: an analysis of pre- and post-treatment biopsies in the multi-center SAKK19/09 study

Blocking programmed cell death 1 in combination with adoptive cytotoxic T-cell transfer eradicates chronic myelogenous leukemia stem cells

Circulating microRNA profiling in patients with advanced non-squamous NSCLC receiving bevacizumab/erlotinib followed by platinum-based chemotherapy at progression (SAKK 19/05)

First-line temozolomide combined with bevacizumab in metastatic melanoma: a multicentre phase II trial (SAKK 50/07)

Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trials

Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction

Immune Surveillance Against a Solid Tumor Fails because of Immunological Ignorance

FTY720 Immunosuppression Impairs Effector T Cell Peripheral Homing Without Affecting Induction, Expansion, and Memory

P16.19 THE EFFECTS OF BEVACIZUMAB ON MR-IMAGING AND 1H-MR-SPECTROSCOPY (MRS) IN PATIENTS WITH HIGH GRADE GLIOMAS

Corrigendum to 'Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trials': [ESMO Open Volume 7, Issue 2, (2022), 100455]

IgD can largely substitute for loss of IgM function in B cells

143PD Bevacizumab and pemetrexed versus pemetrexed alone as maintenance therapy for patients with advanced nonsquamous NSCLC: Results of the expanded SAKK19/09 trial

Immunotherapy with dendritic cells directed against tumor antigens shared with normal host cells results in severe autoimmune disease

Principles of tumor immunosurveillance and implications for immunotherapy

Protective Long-Term Antibody Memory by Antigen-Driven and T Help-Dependent Differentiation of Long-Lived Memory B Cells to Short-Lived Plasma Cells Independent of Secondary Lymphoid Organs

Rapid Peptide Turnover and Inefficient Presentation of Exogenous Antigen Critically Limit the Activation of Self-Reactive CTL by Dendritic Cells

Immunological ignorance of solid tumors

Quantification of fetomaternal hemorrhage by fluorescence microscopy is equivalent to flow cytometry

CD127+ innate lymphoid cells are dysregulated in treatment naïve acute myeloid leukemia patients at diagnosis

P06.08.B Radiation therapy enhances anti-tumor activity of a MET CAR T-based immunotherapy for glioblastoma

A Comparison of T Cell Memory against the Same Antigen Induced by Virus versus Intracellular Bacteria

Suchergebnisse filtern